India
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.18 |
Feb. 5, 2025 | USD 1.83 | 0.32% |
|
India |
|
2 |
28.64 |
Feb. 5, 2025 | USD 11.39 | -2.25% |
|
India |
|
3 |
26.75 |
Feb. 5, 2025 | USD 2.60 | 4.69% |
|
India |
|
4 |
25.33 |
Feb. 5, 2025 | USD 86.22 | 0.33% |
|
India |
|
5 |
18.20 |
Feb. 5, 2025 | USD 22.89 | 1.69% |
|
India |
|
6 |
16.99 |
Feb. 5, 2025 | USD 13.28 | 6.54% |
|
India |
|
7 |
16.03 |
Feb. 5, 2025 | USD 318.28 | 6.11% |
|
India |
|
8 |
16.01 |
Feb. 5, 2025 | USD 28.47 | 2.62% |
|
India |
|
9 |
15.82 |
Feb. 5, 2025 | USD 61.48 | 0.99% |
|
India |
|
10 |
14.94 |
Feb. 5, 2025 | USD 35.66 | 0.08% |
|
India |
|
11 |
14.35 |
Feb. 5, 2025 | USD 169.63 | 1.03% |
|
India |
|
12 |
13.62 |
Feb. 5, 2025 | USD 12.94 | -0.65% |
|
India |
|
13 |
13.55 |
Feb. 5, 2025 | USD 79.50 | 1.94% |
|
India |
|
14 |
13.54 |
Feb. 5, 2025 | USD 7.43 | 1.13% |
|
India |
|
15 |
12.57 |
Feb. 5, 2025 | USD 13.39 | -0.69% |
|
India |
|
16 |
12.05 |
Feb. 5, 2025 | USD 31.97 | -1.62% |
|
India |
|
17 |
11.91 |
Feb. 5, 2025 | USD 62.61 | -0.07% |
|
India |
|
18 |
11.74 |
Feb. 5, 2025 | USD 0.87 | 0.98% |
|
India |
|
19 |
11.55 |
Feb. 5, 2025 | USD 70.10 | 0.15% |
|
India |
|
20 |
10.70 |
Feb. 5, 2025 | USD 28.43 | -3.11% |
|
India |
|
21 |
10.60 |
Feb. 5, 2025 | USD 15.75 | -0.60% |
|
India |
|
22 |
10.45 |
Feb. 5, 2025 | USD 28.35 | -3.29% |
|
India |
|
23 |
10.28 |
Feb. 5, 2025 | USD 1.51 | 0.51% |
|
India |
|
24 |
10.15 |
Feb. 5, 2025 | USD 13.20 | 10.41% |
|
India |
|
25 |
9.82 |
Feb. 5, 2025 | USD 6.96 | -2.20% |
|
India |
|
26 |
9.29 |
Feb. 5, 2025 | USD 31.89 | -0.72% |
|
India |
|
27 |
9.22 |
Feb. 5, 2025 | USD 15.52 | 0.39% |
|
India |
|
28 |
8.80 |
Feb. 5, 2025 | USD 18.90 | 0.16% |
|
India |
|
29 |
8.78 |
Feb. 5, 2025 | USD 19.62 | -1.92% |
|
India |
|
30 |
8.59 |
Feb. 5, 2025 | USD 5.43 | 4.92% |
|
India |
|
31 |
8.51 |
Feb. 5, 2025 | USD 2.87 | -3.36% |
|
India |
|
32 |
8.49 |
Feb. 5, 2025 | USD 6.04 | -0.88% |
|
India |
|
33 |
8.22 |
Feb. 5, 2025 | USD 20.66 | 3.55% |
|
India |
|
34 |
7.95 |
Feb. 5, 2025 | USD 7.22 | 2.82% |
|
India |
|
35 |
7.65 |
Feb. 5, 2025 | USD 9.02 | 0.95% |
|
India |
|
36 |
7.61 |
Feb. 5, 2025 | USD 57.65 | -1.78% |
|
India |
|
37 |
7.52 |
Feb. 5, 2025 | USD 18.92 | 1.06% |
|
India |
|
38 |
7.39 |
Feb. 5, 2025 | USD 7.78 | 2.47% |
|
India |
|
39 |
7.15 |
Feb. 5, 2025 | USD 8.81 | 0.55% |
|
India |
|
40 |
6.94 |
Feb. 5, 2025 | USD 65.83 | 7.21% |
|
India |
|
41 |
6.89 |
Feb. 5, 2025 | USD 15.92 | 12.52% |
|
India |
|
42 |
6.75 |
Feb. 5, 2025 | USD 8.54 | 0.52% |
|
India |
|
43 |
6.70 |
Feb. 5, 2025 | USD 25.02 | 3.19% |
|
India |
|
44 |
6.69 |
Feb. 5, 2025 | USD 10.71 | 10.83% |
|
India |
|
45 |
6.33 |
Feb. 5, 2025 | USD 20.07 | -1.00% |
|
India |
|
46 |
6.31 |
Feb. 5, 2025 | USD 11.53 | -0.38% |
|
India |
|
47 |
6.16 |
Feb. 5, 2025 | USD 7.67 | 6.15% |
|
India |
|
48 |
6.12 |
Feb. 5, 2025 | USD 16.68 | 1.08% |
|
India |
|
49 |
5.79 |
Feb. 5, 2025 | USD 58.59 | -0.06% |
|
India |
|
50 |
5.74 |
Feb. 5, 2025 | USD 17.07 | 1.29% |
|
India |
The Healthcare company in India with the highest Price to Book Ratio (P/B) is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at 39.18.
The Healthcare company in India with the lowest Price to Book Ratio (P/B) is TAKE Solutions Limited (NSE: TAKE.NS) at -19.49.
The top 10 Healthcare companies in India by Price to Book Ratio (P/B) are Sun Pharma Advanced Research Company Limited, Zota Health Care Limited, Wanbury Limited, AstraZeneca Pharma India Limited, GlaxoSmithKline Pharmaceuticals Limited, Vijaya Diagnostic Centre Limited, Abbott India Limited, Poly Medicure Limited, Procter & Gamble Health Limited and Torrent Pharmaceuticals Limited.
The bottom 10 Healthcare companies in India by Price to Book Ratio (P/B) are TAKE Solutions Limited, Krebs Biochemicals & Industries Limited, Ind-Swift Limited, Hinduja Global Solutions Limited, Ind-Swift Laboratories Limited, Nectar Lifesciences Limited, Piramal Enterprises Limited, Venus Remedies Limited, Sastasundar Ventures Limited and Mangalam Drugs & Organics Limited.